These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10625040)

  • 1. Efficacy of colchicine alone or in combination with vinca alkaloids in severe corticoid-resistant thrombocytopenic purpura: six cases.
    Bonnotte B; Gresset AC; Chvetzoff G; Martin F; Lorcerie B; Chauffert B
    Am J Med; 1999 Dec; 107(6):645-6. PubMed ID: 10625040
    [No Abstract]   [Full Text] [Related]  

  • 2. [The combination therapy with vinca-alkaloid slow infusion and cholchicine was effective to refractory idiopathic thrombocytopenic purpura. The patient could receive femoral head replacement in safety].
    Nezu M; Oh H; Cho R; Sato H; Ikegami T; Yokota A; Nakaseko C; Nishimura M; Matsuura Y; Morio S; Hiruma K; Nakamura H; Asai T
    Rinsho Ketsueki; 1996 Feb; 37(2):158-60. PubMed ID: 8852035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients.
    Szczepanik AB; Sikorska A; Slomkowski M; Konopka L
    Int J Lab Hematol; 2007 Oct; 29(5):347-51. PubMed ID: 17824915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective vinca-alkaloid slow infusion therapy of refractory idiopathic thrombocytopenic purpura].
    Wada H; Ata K; Shirato L; Mori H; Sugihara T; Yawata Y
    Rinsho Ketsueki; 1987 Nov; 28(11):1928-34. PubMed ID: 3446865
    [No Abstract]   [Full Text] [Related]  

  • 6. [Idiopathic thrombocytopenic purpura: therapeutic aspects in the adult].
    Canevari A; Pagnucco G; Castelli G; Livraghi A; Santagostino A; Bernasconi C
    Haematologica; 1991 Jun; 76 Suppl 3():124-30. PubMed ID: 1752509
    [No Abstract]   [Full Text] [Related]  

  • 7. Pilot study of ascorbic acid for the treatment of refractory immune thrombocytopenic purpura.
    Jubelirer SJ
    Am J Hematol; 1993 May; 43(1):44-6. PubMed ID: 8317460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology and treatment of idiopathic thrombocytopenic purpura].
    Dan K
    Nihon Ika Daigaku Zasshi; 1996 Oct; 63(5):319-26. PubMed ID: 8937118
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy of chronic idiopathic thrombocytopenic purpura in adults: experiences from Thailand.
    Wanachiwanawin W; Visudhiphan S; Pinankijagum A; Vatanavicharn S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():71-5. PubMed ID: 7886612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of chronic idiopathic thrombocytopenic purpura in adults.
    Berchtold P; McMillan R
    Blood; 1989 Nov; 74(7):2309-17. PubMed ID: 2478227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose biscoclaurine alkaloids together with prednisolone raise platelet counts in chronic idiopathic thrombocytopenic purpura.
    Saito N; Takemori N; Hirai K; Onodera R; Watanabe S; Kohgo Y
    Am J Hematol; 1996 Feb; 51(2):173-4. PubMed ID: 8579066
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methods for treating children with newly diagnosed idiopathic thrombocytopenic purpura--evidence versus opinion based medicine].
    Kühne T
    Praxis (Bern 1994); 2002 Dec; 91(50):2193-6. PubMed ID: 12520728
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of vinca alkaloids in adult patients with refractory chronic idiopathic thrombocytopenia.
    Sikorska A; Słomkowski M; Marlanka K; Konopka L; Górski T
    Clin Lab Haematol; 2004 Dec; 26(6):407-11. PubMed ID: 15595999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eltrombopag in thrombocytopenia.
    Zimmer J; Hentges F; Andrès E
    N Engl J Med; 2008 Mar; 358(10):1072; author reply 1072-3. PubMed ID: 18326076
    [No Abstract]   [Full Text] [Related]  

  • 15. Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept.
    Litton G
    Am J Hematol; 2008 Apr; 83(4):344. PubMed ID: 18186526
    [No Abstract]   [Full Text] [Related]  

  • 16. Melatonin makes splenectomy unnecessary in two patients with idiopathic thrombocytopenic purpura refractory to corticosteroids.
    Todisco M
    J Pineal Res; 2007 Sep; 43(2):214. PubMed ID: 17645700
    [No Abstract]   [Full Text] [Related]  

  • 17. Colchicine therapy for idiopathic thrombocytopenic purpura--an inexpensive alternative.
    Baker RI; Manoharan A
    Aust N Z J Med; 1989 Aug; 19(4):412-3. PubMed ID: 2783090
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term outcomes after treatment for refractory immune thrombocytopenic purpura.
    McMillan R
    N Engl J Med; 2001 May; 344(18):1402-3. PubMed ID: 11336065
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of immune thrombocytopenic purpura in pregnancy.
    Sukenik-Halevy R; Ellis MH; Fejgin MD
    Obstet Gynecol Surv; 2008 Mar; 63(3):182-8. PubMed ID: 18279544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune thrombocytopenic purpura--the changing therapeutic landscape.
    Bromberg ME
    N Engl J Med; 2006 Oct; 355(16):1643-5. PubMed ID: 17050888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.